Hospital Medicines List

Enter at least 4 characters

2 results showing for: 'adalimumab'

  • Restricted. Inj 20 mg per 0.4 ml prefilled syringe - 5% DV Oct-22 to 31 Jul 2026 (PSS)
    • Brand Amgevita
    • Pharmacode2631121
    • Subsidy $190.00
    • Measure / Qty per 1
  • Restricted. Inj 40 mg per 0.8 ml prefilled pen - 5% DV Oct-22 to 31 Jul 2026 (PSS)
    • Brand Amgevita
    • Pharmacode2631105
    • Subsidy $375.00
    • Measure / Qty per 2
  • Restricted. Inj 40 mg per 0.8 ml prefilled syringe - 5% DV Oct-22 to 31 Jul 2026 (PSS)
    • Brand Amgevita
    • Pharmacode2631113
    • Subsidy $375.00
    • Measure / Qty per 2
Adalimumab (Humira - alternative brand)    Medsafe Data Sheets   New Zealand Formulary.   Community Schedule.   HML PDF Schedule - Refer from page 176.
  • Restricted. Inj 20 mg per 0.2 ml prefilled syringe
    • Brand Humira
    • Pharmacode2635062
    • Subsidy $1599.96
    • Measure / Qty per 2
  • Restricted. Inj 20 mg per 0.4 ml syringe
    • Brand Humira
    • Pharmacode2439751
    • Subsidy $1599.96
    • Measure / Qty per 2
    (Humira Inj 20 mg per 0.4 ml syringe to be delisted 01 December 2022)
  • Restricted. Inj 40 mg per 0.8 ml pen
    • Brand HumiraPen
    • Pharmacode2294397
    • Subsidy $1599.96
    • Measure / Qty per 2
  • Restricted. Inj 40 mg per 0.8 ml syringe
    • Brand Humira
    • Pharmacode2207354
    • Subsidy $1599.96
    • Measure / Qty per 2
  • Rectangle page icon symoblising a PDF. PDF
  • Two duplicate pages icon. Click to copy
  • Restriction. Restriction
  • HSS Hospital Supply Status
  • PSS Principal Supply Status
  • dv DV Limit Gives the maximum volume that can be purchased of other brands